Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers

Zaaijer, L.H.; Doorn, H.C. van; Mourits, M.J.E.; Beurden, M. van; Hullu, J.A. de; Adank, M.A.; ... ; Kriege, M. (2016)

Article / Letter to editor

• BRCA mutation
• breast cancer
• ovarian cancer
• survival
• chemotherapy

• All authors: Zaaijer, L.H.; Doorn, H.C. van; Mourits, M.J.E.; Beurden, M. van; Hullu, J.A. de; Adank, M.A.; Lonkhuijzen, L.R.C.W. van; Vasen, H.F.A.; Slangen, B.F.M.; Gaarenstroom, K.N.; Zweemer, R.P.; Vencken, P.M.L.H.; Seynaeve, C.; Kriege, M.
• Date: 2016-11-08
• Journal: British Journal of Cancer
• Volume: 115
• Issue: 10
• Pages: 1174 - 1178
• DOI: doi:10.1038/bjc.2016.333